These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 19876745)

  • 21. The FDA should eliminate the ambiguities in the current BCS biowaiver guidance and make public the drugs for which BCS biowaivers have been granted.
    Benet LZ; Larregieu CA
    Clin Pharmacol Ther; 2010 Sep; 88(3):405-7. PubMed ID: 20668447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solubility Determination of Active Pharmaceutical Ingredients Which Have Been Recently Added to the List of Essential Medicines in the Context of the Biopharmaceutics Classification System-Biowaiver.
    Plöger GF; Hofsäss MA; Dressman JB
    J Pharm Sci; 2018 Jun; 107(6):1478-1488. PubMed ID: 29421214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biowaiver: an alternative to in vivo pharmacokinetic bioequivalence studies.
    Mishra V; Gupta U; Jain NK
    Pharmazie; 2010 Mar; 65(3):155-61. PubMed ID: 20383933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral absorption of poorly water-soluble drugs: computer simulation of fraction absorbed in humans from a miniscale dissolution test.
    Takano R; Sugano K; Higashida A; Hayashi Y; Machida M; Aso Y; Yamashita S
    Pharm Res; 2006 Jun; 23(6):1144-56. PubMed ID: 16715363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Provisional in-silico biopharmaceutics classification (BCS) to guide oral drug product development.
    Wolk O; Agbaria R; Dahan A
    Drug Des Devel Ther; 2014; 8():1563-75. PubMed ID: 25284986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral biopharmaceutics tools - time for a new initiative - an introduction to the IMI project OrBiTo.
    Lennernäs H; Aarons L; Augustijns P; Beato S; Bolger M; Box K; Brewster M; Butler J; Dressman J; Holm R; Julia Frank K; Kendall R; Langguth P; Sydor J; Lindahl A; McAllister M; Muenster U; Müllertz A; Ojala K; Pepin X; Reppas C; Rostami-Hodjegan A; Verwei M; Weitschies W; Wilson C; Karlsson C; Abrahamsson B
    Eur J Pharm Sci; 2014 Jun; 57():292-9. PubMed ID: 24189462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishing the pharmaceutical quality of Chinese herbal medicine: a provisional BCS classification.
    Fong SY; Liu M; Wei H; Löbenberg R; Kanfer I; Lee VH; Amidon GL; Zuo Z
    Mol Pharm; 2013 May; 10(5):1623-43. PubMed ID: 23473440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BCS Biowaivers: Similarities and Differences Among EMA, FDA, and WHO Requirements.
    Davit BM; Kanfer I; Tsang YC; Cardot JM
    AAPS J; 2016 May; 18(3):612-8. PubMed ID: 26943914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional intestinal drug permeation: biopharmaceutics and drug development.
    Lennernäs H
    Eur J Pharm Sci; 2014 Jun; 57():333-41. PubMed ID: 23988845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Applying Biopharmaceutical Classification System (BCS) Criteria to Predict Oral Absorption of Drugs in Dogs: Challenges and Pitfalls.
    Papich MG; Martinez MN
    AAPS J; 2015 Jul; 17(4):948-64. PubMed ID: 25916691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Biopharmaceutical classification system--experimental model of the prediction of drug bioavailability].
    Golovenko NIa; Borisiuk IIu
    Biomed Khim; 2008; 54(4):392-407. PubMed ID: 18988456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Biopharmaceutics Classification System (BCS) and the Biopharmaceutics Drug Disposition Classification System (BDDCS): Beyond guidelines.
    Charalabidis A; Sfouni M; Bergström C; Macheras P
    Int J Pharm; 2019 Jul; 566():264-281. PubMed ID: 31108154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In silico prediction of drug dissolution and absorption with variation in intestinal pH for BCS class II weak acid drugs: ibuprofen and ketoprofen.
    Tsume Y; Langguth P; Garcia-Arieta A; Amidon GL
    Biopharm Drug Dispos; 2012 Oct; 33(7):366-77. PubMed ID: 22815122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. G.L. Amidon, H. Lennernas, V.P. Shah, and J.R. Crison. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability, Pharm Res 12, 413-420, 1995--backstory of BCS.
    Shah VP; Amidon GL
    AAPS J; 2014 Sep; 16(5):894-8. PubMed ID: 24961917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purely in silico BCS classification: science based quality standards for the world's drugs.
    Dahan A; Wolk O; Kim YH; Ramachandran C; Crippen GM; Takagi T; Bermejo M; Amidon GL
    Mol Pharm; 2013 Nov; 10(11):4378-90. PubMed ID: 24094040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Provisional biopharmaceutical classification of some common herbs used in Western medicine.
    Waldmann S; Almukainzi M; Bou-Chacra NA; Amidon GL; Lee BJ; Feng J; Kanfer I; Zuo JZ; Wei H; Bolger MB; Löbenberg R
    Mol Pharm; 2012 Apr; 9(4):815-22. PubMed ID: 22352942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physicochemical profiling (solubility, permeability and charge state).
    Avdeef A
    Curr Top Med Chem; 2001 Sep; 1(4):277-351. PubMed ID: 11899112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of drug metabolism for prediction of intestinal permeability (dagger).
    Chen ML; Yu L
    Mol Pharm; 2009; 6(1):74-81. PubMed ID: 19132929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Forecasting oral absorption across biopharmaceutics classification system classes with physiologically based pharmacokinetic models.
    Hansmann S; Darwich A; Margolskee A; Aarons L; Dressman J
    J Pharm Pharmacol; 2016 Dec; 68(12):1501-1515. PubMed ID: 27781273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variance based global sensitivity analysis of physiologically based pharmacokinetic absorption models for BCS I-IV drugs.
    Melillo N; Aarons L; Magni P; Darwich AS
    J Pharmacokinet Pharmacodyn; 2019 Feb; 46(1):27-42. PubMed ID: 30552544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.